Open-label Study of ASP2151 in Herpes Simplex Patients
NCT02209324
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
275
Enrollment
INDUSTRY
Sponsor class
Conditions
Herpes Simplex
Interventions
DRUG:
ASP2151
Sponsor
Maruho Co., Ltd.